ATOSSA THERAPEUTICS, INC. (ATOS): auditor change — Atossa Therapeutics dismisses BDO, appoints Ernst & Young as new auditor

ATOSSA THERAPEUTICS, INC.

On May 17, 2023, Atossa dismissed BDO USA LLP as independent auditor; no accounting disagreements.
BDO's 2021/2022 audit reports were unqualified; no adverse opinions or scope modifications.
A 2020 material weakness in internal controls over financial reporting was remediated by end of 2021.
EY appointed as new auditor for fiscal year ending December 31, 2023.
No prior consultations with EY on accounting principles or disagreements.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

ATOSSA THERAPEUTICS, INC. dismissed BDO USA LLP as its auditor.

Action: dismissal
Auditor: BDO USA LLP
Successor: Ernst & Young LLP

Exact text from the filing

On May 17, 2023 (the “ Effective Date ”), the Audit Committee dismissed BDO USA LLP (“ BDO ”) as the Company’s independent registered public accounting firm, effective as of that date.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

ATOSSA THERAPEUTICS, INC. engaged Ernst & Young LLP as its auditor.

Action: engagement
Auditor: Ernst & Young LLP

Exact text from the filing

The Audit Committee, on and effective as of the Effective Date, appointed Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.

View on SEC.gov

Browse all auditor changes →

ATOSSA THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001437749-23-015468

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.